Research-use fastGEN NGS kit for JAK2, CALR, and MPL mutation profiling in human myeloproliferative neoplasm workflows, supported by GENOVESA bioinformatic analysis.
Manufactured by BioVendor, the fastGEN MPN Cancer Kit is designed for molecular diagnostics research of myeloproliferative neoplasms. It focuses on activating somatic mutations in JAK2, MPL, and CALR that are associated with constitutive activation of the JAK-STAT signaling pathway.
Relevant MPN content from the BioVendor technical data, arranged for quick laboratory review.
Designed for molecular diagnostics research of myeloproliferative neoplasms (MPN).
Focuses on JAK2, MPL, and CALR, the key genes associated with activating somatic mutations in MPN.
Supports research related to polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Addresses mutation profiling linked with JAK-STAT signaling pathway activation.
Supports WHO-classification-aligned molecular diagnostics discussions for accurate diagnosis, disease monitoring, and targeted therapy selection.
Built on the BioVendor fastGEN system for one-step NGS library preparation.
BioVendor provides RUO instructions, safety information, run assignment resources, application documents, and a hemato-oncology product brochure to support implementation planning.
Example Instructions for Use (RUO) are available for workflow reference.
MSDS / Safety Information (RUO) resources support laboratory handling review.
fastGEN sample sheet and application documents are listed for sequencing run planning.
Product brochure support includes cutting-edge NGS solution information for hemato-oncology.
Our team can help with RUO product availability, GENOVESA workflow planning, platform compatibility, and implementation support.
